Worth reading
70In focus
Scored from 3 of 5 sectionsDirection
Improvement
Direction inferred from the company’s description.Scale
9631111000
¥Wording
Conditional
How definitive the wording is.Details of issuance or disposal
Partial exercise of the 14th Series of Stock Acquisition Rights
Who receives how much385,244,440Shares
385,244,440 common shares
Ichigo Trust: 10 rights exercised in this transaction, with 90 rights remaining unexercised
The lower thin line represents the existing number of shares to which these shares will be added.
Amount of funds to be raised
Proceeds from this exercise: ¥9,631,111,000; estimated net proceeds: Not disclosed
Existing Shares and Increase
+9.93%Rate of increase
3,880,388,022 shares4,265,632,462Shares
Based on voting rights, an increase of 3,852,444 from 38,801,993 before this exercise (approximately 9.93%)
The dilution rate shows what proportion the newly issued shares represent of the existing shares. The higher the proportion, the more the value and voting rights per share are diluted.
Terms of the stock acquisition rights
Exercise price
¥25 per share. Amendment provisions and the floor for amendments: Not disclosed
Number of Stock Acquisition Rights
Total issued: 100 rights; exercised in this transaction: 10 rights; remaining unexercised: 90 rights
Payment date
13 May 2026 (exercise date)
Most recent equity financing
15 July 2025: issuance of the 14th Series of Stock Acquisition Rights (the detailed amount is not stated in this document)
Impact on Business Performance
The Company believes that this exercise will contribute to strengthening its financial position and significantly support the advancement of its business going forward.
| Item | Details |
|---|---|
| Type of issuance or disposal | Partial exercise of the 14th Series of Stock Acquisition Rights |
| Number of shares to be issued or disposed of | 385,244,440 common shares |
| Amount of funds to be raised | Proceeds from this exercise: ¥9,631,111,000; estimated net proceeds: Not disclosed |
| Payment date | 13 May 2026 (exercise date) |
| Intended allottee | Ichigo Trust: 10 rights exercised in this transaction, with 90 rights remaining unexercised |
| Dilution Rate | Based on voting rights, an increase of 3,852,444 from 38,801,993 before this exercise (approximately 9.93%) |
| Total number of issued shares | 3,880,388,022 common shares and 5,540 Series E preferred shares → 4,265,632,462 common shares and 5,540 Series E preferred shares（Common shares increased by approximately 9.93%） |
| Exercise price | ¥25 per share. Amendment provisions and the floor for amendments: Not disclosed |
| Number of Stock Acquisition Rights | Total issued: 100 rights; exercised in this transaction: 10 rights; remaining unexercised: 90 rights |
| Most recent equity financing | 15 July 2025: issuance of the 14th Series of Stock Acquisition Rights (the detailed amount is not stated in this document) |
| Impact on Business Performance | The Company believes that this exercise will contribute to strengthening its financial position and significantly support the advancement of its business going forward. |
Items this document does not state (17)
Issue price and disposal priceTotal issue valueEstimated issuance expensesSpecific use of fundsIntended allottee's holding policyBasis for determining the amount to be paidExercise periodTransfer restriction periodConditions for lifting transfer restrictionsReason for acquisition without considerationCategories and Number of Persons CoveredTotal Stock-Based CompensationUnderwriter / lead underwriterOverallotmentStock Split RatioProcedures under the Corporate Code of ConductMajor shareholders after the offering
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.The Company believes that this exercise will contribute to strengthening its financial position and significantly support the advancement of its business going forward.
How to read this page
This is not the documentKomori reads the disclosure the company filed and writes this summary. Figures are as stated by the company and are not audited.
Weight is not a verdictIt measures how much this changes what the company had already told the market. It is not a view on the shares.
Corrections happenIf the company reissues this disclosure, the page is rebuilt from the corrected version and the revision number moves up.